Clinical Trials Browser

Phase 2 × Inhibition, Psychological × 90 days × Clear all

NCT04917042 2026-02-04

Tazemetostat in Malignant Peripheral Nerve Sheath Tumors

Phase 2 Active not recruiting

10 enrolled 12 charts

Inhibition, Psychological, Sarcoma, Nerve Sheath Neoplasms, Neurofibrosarcoma